Implications of Centers for Medicare & Medicaid Services Severe Sepsis and Septic Shock Early Management Bundle and Initial Lactate Measurement on the Management of Sepsis

Chest

Volumn 154, Issue 2, 2018, Pages 302-308

  Han, Xuan ^a   Edelson, Dana P ^a,b   Snyder, Ashley ^c   Pettit, Natasha ^a   Sokol, Sarah ^a   Barc, Carmen ^a   Howell, Michael D ^d   Churpek, Matthew M ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Health Benchmarks   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^d GOOGLE INC   (United States)

Author keywords

critical care; lactic acid; sepsis; septic shock

Indexed keywords

ANTIBIOTIC AGENT; LACTIC ACID; BIOLOGICAL MARKER;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; PATIENT CARE; PRIORITY JOURNAL; SEPTIC SHOCK; UNIVERSITY; BLOOD; CARE BUNDLE; GOVERNMENT; ILLINOIS; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SEPSIS; UNITED STATES;

BIOMARKERS; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); CHICAGO; FEMALE; HOSPITAL MORTALITY; HUMANS; LACTATES; MALE; MIDDLE AGED; PATIENT CARE BUNDLES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; UNITED STATES;

EID: 85047226230     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2018.03.025     Document Type: Article

References (23)

1. Liu, V., Escobar, G.J., Green, J.D., et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312 (2014), 90–92.
2. Martin, G.S., Mannino, D.M., Eaton, S., Moss, M., The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:16 (2003), 1546–1554.
3. Angus, D.C., Line-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., Pinsky, M.R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:7 (2001), 1303–1310.
4. Dellinger, R.P., Levy, M.M., Rhodes, A., et al., Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:2 (2013), 580–637.
5. Specifications Manual for National Hospital Inpatient Quality Measures Discharges 10-01-15 (4Q15) through 06-30-16 (2Q16). Specifications manual for National Inpatient Quality Measures. The Joint Commission. 2016.
6. Nguyen, H.B., Corbett, S.W., Steel, R., et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med 35:4 (2007), 1105–1112.
7. Singer, M., Deutschman, C.S., Seymour, C.W., et al. The Third International Consensus Definitions for Sepsis and Septich Shock (Sepsis-3). JAMA 315:8 (2016), 801–810.
8. Seymour, C.W., Liu, V.X., Iwashyna, T.J., et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:8 (2016), 762–774.
9. Seymour, C.W., Gesten, F., Prescott, H.C., et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376:23 (2017), 2235–2244.
10. Shapiro, N.I., Howell, M.D., Talmor, D., et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 45:5 (2005), 524–528.
11. Nguyen, H.B., Loomba, M., Yang, J.J., Jacobsen, G., Shah, K., Otero, R.M., Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32:8 (2004), 1637–1642.
12. Mikkelsen, M.E., Miltiades, A.N., Gaieski, D.F., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37:5 (2009), 1670–1677.
13. Churpek, M.M., Zadravecz, F.J., Winslow, C., Howell, M.D., Edelson, D.P., Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med 192:8 (2015), 958–964.
14. Churpek, M.M., Yuen, T.C., Winslow, C., et al. Multicenter development and validation of a risk stratification tool for ward patients. Am J Respir Crit Care Med 190:6 (2014), 649–655.
15. Bone, R.C., Balk, R.A., Cerra, F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:6 (1992), 1644–1655.
16. Liu, V., Morehouse, J.W., Soule, J., Whippy, A., Escobar, G.J., Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Ann Am Thorac Soc 10:5 (2013), 466–473.
17. Liu, V.X., Morehouse, J.W., Marelich, G.P., et al. Multicenter implementation of a treatment bundle for patients with sepsis and intermediate lactate values. Am J Respir Crit Care Med 193:11 (2016), 1264–1270.
18. Venkatesh, A.K., Slesinger, T., Whittle, J., et al. Preliminary performance on the new CMS sepsis-1 national quality measure: early insights from the Emergency Quality Network (E-QUAL). Ann Emerg Med 71:1 (2017), 10–15.
19. Ramsdell, T.H., Smith, A.N., Kerkhove, E., Compliance with updated sepsis bundles to meet new sepsis core measure in a tertiary care hospital. Hosp Pharm 52:3 (2017), 177–186.
20. Esper, A.M., Moss, M., Lewis, C.A., Nisbet, R., Mannino, D.M., Martin, G.S., The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med 34:10 (2006), 2576–2582.
21. Zahar, J.R., Timsit, J.F., Garrouste-Orgeas, M., et al. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med 39:8 (2011), 1886–1895.
22. Leligdowicz, A., Dodek, P.M., Norena, M., Wong, H., Kumar, A., Kumar, A., Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med 189:10 (2014), 1204–1213.
23. Kumar, A., Roberts, D., Wood, K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:6 (2006), 1589–1596.